@FierceBiotech: RT @NickPaulTaylor: EuroBiotech: NeuroSearch convicted of stock manipulation, VBL IPO unravels, Prosensa plans EMA filing and more. Report | Follow @FierceBiotech
@DamianFierce: CF biotech ProQR, pursuing a $75M IPO, employs a "happiness manager." | Follow @DamianFierce
@EmilyMFierce: Glaxo quietly edges toward Ebola vaccine but clinical barriers remain. FierceVaccines story | Follow @EmilyMFierce
> The FDA wants more data on Acura Pharmaceuticals' ($ACUR) investigational painkiller, signaling that the company may need to run another clinical trial to demonstrate the drug's abuse deterrence. Story
> Ligand Pharmaceuticals ($LGND) has signed a deal with Avion Pharmaceuticals, lending out its Captisol platform for use in four in-development drugs. More
> Indian Prime Minister Narendra Modi is considering launching state-funded research institutions focused on biotech and pharma. Article
Medical Device News
@FierceMedDev: Researchers explore 'shape-shifting' material for facial reconstruction. More | Follow @FierceMedDev
@StacyALawrence: ICYMI: Intel, Michael J. Fox Foundation start smartwatch study to track Parkinson's patients. Story | Follow @StacyALawrence
@VarunSaxena2: RT @FierceMedicalDev: We're looking for fierce women at the top of their game in #medtech. Learn more about how to nominate. More | Follow @VarunSaxena2
@EmilyWFierce: Senate democrats outlining a proposal to crack down on corporate tax inversions. Story via The Wall Street Journal | Follow @EmilyWFierce
> Foundation Medicine teams with MD Anderson for new trial of cancer Dx. News
> Top U.S. senator urges Hospira to abandon inversion plans. Story
> FDA launches pilot program for qualification of medical device development tools. Article
> Researchers explore 'shape-shifting' material for facial reconstruction. More
Pharma News
@FiercePharma: ICYMI earlier: Skeptical U.K. watchdogs decide to back Gilead's hep C star Sovaldi. News | Follow @FiercePharma
@EricPFierce: Amgen recalls Aranesp from UK, Russia, 7 other countries after polyester particles found in syringes. FiercePharmaManufacturing story | Follow @EricPFierce
@CarlyHFierce: Valeant, Pershing Square: Bring on the SEC insider trading probe. More | Follow @CarlyHFierce
> Roche's Avastin nabs quick FDA nod for cervical cancer use. News
> NICE Zytiga snub is 'plainly illogical,' critics say. Story
> Bloomberg: Roche negotiating for rest of Chugai for $10B. More